Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate…
VLA2001 was well-tolerated, demonstrating a statistically significant better tolerability profile compared to active comparator…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.